Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Shengfeng Development (SFWL) Cash & Equivalents (2021 - 2025)

Shengfeng Development's Cash & Equivalents history spans 5 years, with the latest figure at $35.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 1.73% year-over-year to $35.3 million; the TTM value through Dec 2025 reached $35.3 million, up 1.73%, while the annual FY2025 figure was $35.3 million, 1.73% up from the prior year.
  • Cash & Equivalents reached $35.3 million in Q4 2025 per SFWL's latest filing, up from $34.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $35.3 million in Q4 2025 to a low of $18.6 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $27.3 million, with a median of $26.7 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: grew 29.84% in 2024, then grew 1.73% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $18.6 million in 2021, then rose by 14.17% to $21.3 million in 2022, then increased by 25.56% to $26.7 million in 2023, then increased by 29.84% to $34.7 million in 2024, then rose by 1.73% to $35.3 million in 2025.
  • Per Business Quant, the three most recent readings for SFWL's Cash & Equivalents are $35.3 million (Q4 2025), $34.7 million (Q4 2024), and $26.7 million (Q4 2023).